Five years ago, a new facility opened on the University of Missouri campus with an ambitious promise: speed the journey from lab-bench discoveries to treatments that could improve — and even save — lives.
Today, behind the glass walls of the Roy Blunt NextGen Precision Health building, that promise is taking shape.
In one lab, researchers are finding ways to prevent cancer before it starts. Down the hall, scientists are working to delay the onset of Alzheimer’s disease. Around the corner, investigators are developing gene therapies to slow the progression of heart failure.
This is precision health at Mizzou — research happening across disciplines and under one roof, with scientists, clinicians and industry partners working together to improve the lives of Missourians and people worldwide.
On Oct. 20, Mizzou hosted a celebration for the fifth anniversary of the Roy Blunt NextGen Precision Health building led by Vice Chancellor for Research Tom Spencer, above, and Richard Barohn, professor of neurology.
According to University of Missouri President Mun Choi's Oct. 21 blog, research productivity from principal investigators in the building has grown considerably since NextGen opened in 2021. The building now houses more than 530 occupants, including more than 50 research groups pioneering innovations in key areas including neuroscience and aging, cancer and immunology, AI and data science, reproductive healthy and biology, advanced imaging, biomaterials engineering and cardiovascular and metabolic disorders.
Read full story featuring 12 NextGen researchers on the Show Me Mizzou website.
Read President Choi's Oct. 21 blog.